Advances in Diagnosis of Respiratory Virus Infections by Loeffelholz, Michael & Chonmaitree, Tasnee
Hindawi Publishing Corporation
International Journal of Microbiology
Volume 2010, Article ID 126049, 5 pages
doi:10.1155/2010/126049
Review Article
Advancesin Diagnosis of Respiratory VirusInfections
Michael Loeffelholz1 andTasneeChonmaitree1,2
1Department of Pathology, The University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-0740, USA
2Department of Pediatrics, The University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-0371, USA
Correspondence should be addressed to Michael Loeﬀelholz, mjloeﬀe@utmb.edu
Received 8 May 2010; Accepted 6 October 2010
Academic Editor: Eduardo Dei-Cas
Copyright © 2010 M. Loeﬀelholz and T. Chonmaitree. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
The diagnosis of respiratory virus infections has evolved substantially in recent years, with the emergence of new pathogens
and the development of novel detection methods. While recent advances have improved the sensitivity and turn-around time
of diagnostic tests for respiratory viruses, they have also raised important issues such as cost, and the clinical signiﬁcance of
detecting multiple viruses in a single specimen by molecular methods. This article reviews recent advances in specimen collection
and detection methods for diagnosis of respiratory virus infections, and discusses the performance characteristics and limitations
of these methods.
1.Introduction
Respiratory virus infections have a major impact on health.
Acute respiratory illnesses, mostly caused by viruses, are
the most common illness experienced by otherwise healthy
children and adults worldwide. Upper respiratory tract
infections (URIs) such as common cold are exceedingly
prevalent in infants and young children and continue to be
common in older children and adults. Infants and young
children may have 3–8 episodes of cold per year; those who
attend daycare centers may have many more episodes per
year [1–4]. URI can lead to complications such as acute
otitis media, asthma exacerbation, and lower respiratory
tract infections (LRIs). While LRIs such as pneumonia,
bronchitis,andbronchiolitisoccurmuchlessfrequently,they
cause higher morbidity and some mortality, thus they are
associated with high impact and greater healthcare costs.
Approximately one third of children develop an LRI in the
ﬁrst year of life; LRI incidence decreases to 5%–10% during
early school year, and 5% during preadolescent to healthy
adult years [5, 6].
Common respiratory viruses include inﬂuenza A and B,
respiratory syncytial virus A and B, parainﬂuenza virus types
1–3, adenovirus, rhinovirus, human metapneumovirus, and
coronavirus types OC43 and 229E. Less common respiratory
viruses include parainﬂuenza virus type 4, inﬂuenza virus C,
and speciﬁc types of enteroviruses. The signiﬁcance of
more recently discovered viruses such as human bocavirus,
coronavirus NL63, and HKU1 has yet to be elucidated
[7, 8].
Clinical presentations of respiratory virus infections
overlap among those caused by various viruses. In addition,
clinical manifestations may mimic those of diseases caused
by bacteria. Therefore, antibiotics are most often used in
these infections, most of them unnecessarily. Furthermore,
LRIs often require hospitalization for management such as
intravenous antibiotics and symptomatic and supportive
treatment. Speciﬁc antiviral treatment for respiratory virus
infections is only available for inﬂuenza. Respiratory viral
diagnosisisanintegralpartofpatientmanagement.Accurate
diagnosis of speciﬁc respiratory virus infection not only
improves the knowledge of disease the patient has but also
can aﬀect patient management and help prevent secondary
spread of the infection. Rapid viral diagnosis may result
in discontinuation of unnecessary antibiotics, initiation
of antiviral drug for inﬂuenza, reduction of costs related
to reduction of unnecessary investigations, and shortened
hospital stay [9–11].
This paper describes up-to-date information on labora-
tory methods presently available in the diagnostic virology
laboratories and those upcoming for detection of respiratory
viruses.2 International Journal of Microbiology
2.SpecimenCollection
2.1. Novel Swab Types. Perhaps one of the most signiﬁcant
advances in the detection of respiratory viruses is the recent
introduction of novel swab types such as ﬂocked swabs.
Flocked swabs consist of nylon ﬁbers perpendicular to the
swab shaft. Unlike standard woven rayon swabs which trap
sample material, the ﬁbers of ﬂocked swabs act like a brush
to collect respiratory epithelial cells and eﬃciently release
them in transport medium [12]. Studies comparing nasal
ﬂocked swabs to nasal aspirates from children showed that
the sensitivity of ﬂocked swabs was at least equivalent
for the detection of a variety of respiratory viruses [13,
14]. Similar studies comparing ﬂocked swabs to woven
rayon swabs in adult patients are needed. Another type of
novel swab material is polyurethane foam. A recent study
demonstrated that polyurethane foam swabs of the anterior
nares performed better than ﬂocked swabs for detection of
inﬂuenza viruses in children by a rapid antigen test [15].
2.2. Performance of Swab Specimens versus Aspirates/Washes.
Traditionally, nasal washes and aspirates have been con-
sidered to be superior to swab specimens for isolation of
respiratory viruses in cell culture and detection of viral
antigens in immunoassays [16–18]. However, with contem-
porary diagnostic assays and the use of ﬂocked swabs, this
superiority may be mitigated [13, 14, 19]. In one recent
study,bothnasopharyngealandnasalswabswerefoundtobe
superiortonasalwashesforthedetectionofinﬂuenzaviruses
by a rapid antigen immunoassay in pediatric subjects [20].
A recently advocated sampling approach is the swabbing of
both the throat and anterior nares as a single specimen.
A recent study showed excellent sensitivity of PCR for
inﬂuenza virus and RSV performed on combined nose-
throat specimens [21].
2.3. Patient/Parent-Collected Swabs. Parent-collected respi-
ratory swabs have been utilized in research studies, where
they have been shown to yield sensitivity equivalent to
that of healthcare worker-collected swabs when combined
with PCR testing [22]. A practical limitation to parent- or
patient-collected swabs is the availability of viral transport
medium. However, a recent study showed that viral RNA
was stable on dry respiratory swabs, and that these swabs
were more sensitive than traditionally collected respiratory
specimens for detection of viruses by nucleic acid sequence-
based ampliﬁcation (NASBA) [23].
3.LaboratoryDiagnosis
3.1. Antigen Detection Tests
3.1.1. Rapid Immunoassays. Providing a result at the point
of care in less than 30 minutes, rapid immunoassays are
widely used for the detection of inﬂuenza viruses and
RSV. Rapid immunoassay formats include membrane-based
enzymeimmunoassay,lateralﬂowimmunochromatography,
andopticalimmunoassay.Mosttestresultsarereadmanually
by eye although one test includes an automated reader. The
sensitivity of rapid RSV immunoassays in pediatric patients
is generally higher than that of cell culture due to the
lability of RSV [24]. The sensitivity of rapid immunoassays
also depends on the study population; children often shed
respiratory viruses at higher titers [25]a n df o rl o n g e rt i m e
periods than do adults [26]. In spite of the poor sensitivity
of these tests for detection of inﬂuenza virus, positive results
in the emergency setting or from hospitalized patients can
signiﬁcantly impact patient management [27, 28]. Recent
evaluations of rapid immunoassays for detection of the novel
2009 inﬂuenza A (H1N1) virus have demonstrated variable
and generally poor sensitivity, in some cases 25% or lower
compared to reverse transcriptase (RT)-PCR [29–31]. These
data highlight the limitations of diagnostic tests that target
infectious agents such as inﬂuenza A virus, that have the
capability to evolve signiﬁcantly and rapidly.
3.1.2. Direct Fluorescent Antibody Tests. Direct ﬂuorescent
antibody (DFA) staining of viral antigens in patient spec-
imens is generally considered to be more sensitive than
rapid immunoassays [32]. The speciﬁcity of DFA is high
but depends on experienced technologists. Food and Drug
Administration- (FDA-) cleared commercial DFA reagents
have long been available for detection and identiﬁcation of
inﬂuenza A and B viruses, RSV, parainﬂuenza viruses 1–
3, and adenovirus. Recent advances in DFA tests include
the availability of FDA-cleared commercial DFA reagents
for detection of human metapneumovirus. A study showed
excellent sensitivity (95% versus RT-PCR) of a human
metapneumovirus DFA performed on nasopharyngeal aspi-
rates from children [33]. DFA was substantially more
sensitive than rapid immunoassays for detection of the novel
2009 inﬂuenza A (H1N1) virus, though less sensitive than
virus isolation and/or RT-PCR [31, 34].
3.2. Virus Isolation. Long considered the gold standard for
detection of respiratory viruses, the turn-around time of
conventional cell culture in tubes for respiratory viruses
is generally too long to be clinically relevant [35]. When
performed on fresh specimens maintained at refrigerated
temperature, virus isolation has excellent sensitivity for
mostrespiratoryviruses.Theuseofcentrifugation-enhanced
(shell vial) culture and mixed cell lines in the same vial has
decreased turn-around time to 24–48 hours and streamlined
workﬂow [36]. A study showed that shell vials containing
mixed cell lines had similar sensitivity as conventional tube
culture for detection of inﬂuenza and parainﬂuenza viruses.
For RSV detection, the shell vial system was more sensitive
than conventional culture, but less sensitive than a direct
antigen test [37]. Virus isolation in shell vials was highly
sensitive for detection of 2009 inﬂuenza A (H1N1) [31].
3.3. Serology. The diagnostic utility of serology generally is
limited by the need to collect both acute and convalescent
sera to identify either seroconversion or a fourfold rise in
antibody titer. As such, serologic methods that detect IgG
responses usually have little impact on patient management.International Journal of Microbiology 3
Tests that detect IgM antibodies can detect acute infection,
but sensitivity is reduced because serum IgM levels are often
low due to repeated exposure to vaccine or circulating virus.
Recent advances in serologic assays for respiratory viruses
are largely limited to novel microagglutination assays that
detect and measure antibody titers to novel inﬂuenza A virus
subtypes. These assays utilize engineered reporter viruses—
a lentiviral vector pseudotyped to contain the inﬂuenza
hemagglutinin protein that eliminates the need for enhanced
biocontainment facilities [38]. The pseudotyped lentiviral
particles express the hemagglutinin protein but are replica-
tion deﬁcient. Microneutralization assays employing either
infectious or noninfectious reporter viruses are performed
primarily for retrospective studies, epidemiologic surveys,
and vaccine trials and have limited implications for routine
diagnostics.
3.4. Nucleic Acid Ampliﬁcation Tests. Nucleic acid ampliﬁca-
tion methods such as RT-PCR and nucleic acid sequence-
basedampliﬁcation(NASBA)arebecomingmorecommonly
used for detection of inﬂuenza virus and other respiratory
viruses. Using realtime, ﬂuorescent detection of ampliﬁed
product, laboratories are able to perform molecular tests in
lessthan3hours.Highspeciﬁcityrequiresjudiciousselection
of primers and probes, optimization of ampliﬁcation con-
ditions, and interpretation of results. Continuous adherence
to laboratory protocol is essential to avoid false positives
due to carryover contamination. Due to the limited number
and cost of FDA-cleared nucleic acid ampliﬁcation tests,
many laboratories perform tests developed and veriﬁed in
house (referred to as laboratory-developed tests (LDTs)).
LDTs (and laboratory-veriﬁed commercial kits) are viable
optionsforthedetectionofcommonrespiratoryvirusessuch
as RSV [39], as well as viruses for which no FDA-cleared
commercial assays are available such as human bocavirus
[40]. The development and veriﬁcation of LDTs require
considerable resources and expertise. As well, the perfor-
mancecharacteristicsofLDTsmayvarysigniﬁcantlybetween
laboratories. Consensus recommendations on veriﬁcation
and quality assurance of laboratory tests, including LDTs, are
available [41].
3.4.1. Real-Time PCR. In real-time PCR, ampliﬁcation (as
detected by an increase in ﬂuorescence) and analysis occur
simultaneously. Real-time PCR is well suited for quantitative
analysis, but currently available commercially kits for detec-
tion of respiratory virus nucleic acids have only qualitative
claims. Most real-time PCR instruments are limited in the
number of emission channels available for multiplexing. As
a result, commercially available multiplex real-time PCR kits
are generally limited to the detection of four or fewer nucleic
acid targets. One of the targets is usually an internal control.
FDA-cleared real-time RT-PCR assays are currently available
for the detection of inﬂuenza A (including subtypes) and
inﬂuenza B viruses, RSV, parainﬂuenza viruses 1, 2, and 3,
and human metapneumovirus. Studies have demonstrated
that molecular ampliﬁcations methods including real-time
RT-PCR provide the most sensitive detection of respiratory
viruses [42, 43].
3.4.2. Conventional PCR. Conventional PCR requires the
postampliﬁcation detection of PCR product (e.g., via
sequence-speciﬁc DNA probes, or electrophoresis). Either
format allows for highly multiplexed assays that are able
to detect more pathogens in a single PCR reaction than
real-time PCR. An FDA-cleared assay utilizing conventional
RT-PCR and a microarray of sequence-speciﬁc beads can
detect RSV, inﬂuenza A (including subtypes) and inﬂuenza
B viruses, parainﬂuenza viruses 1, 2, and 3, human metap-
neumovirus, rhinoviruses, and adenoviruses from a single
RT-PCR reaction. This PCR assay format provides sensitive
detection of inﬂuenza viruses, as well as the ability to detect
a broad scope of respiratory pathogens [31].
The high sensitivity of molecular ampliﬁcation tests has
madetheinterpretationofpositive resultschallenging.These
assays detect respiratory virus nucleic acid in the absence of
symptoms[44–46]andalsoindicatethatnucleicacidspersist
following infection [47, 48]. In addition, these methods
frequently detect multiple pathogens in the same specimen
[47]. Additional studies are needed to fully understand the
clinical signiﬁcance of these data, as well as the etiologic
role of newly discovered agents such as human bocavirus.
Quantitative real-time PCR methods have proven useful in
this regard [49].
4. Summary
Duringthepastseveralyears,wehavewitnessedanexplosion
of improvements in respiratory virus diagnostics, from
novel specimen collection instruments to highly sensitive
and multiplexed nucleic acid ampliﬁcation tests. With the
expanding list of antigen and molecular-based tests, it is now
possible for laboratories to oﬀer comprehensive testing for
respiratory viruses without even performing virus isolation.
However, cell culture still remains the gold standard in
many laboratories. Recent advances have also been made
to this traditional approach to improve the turn-around
time by using a combination of shell vial cultures and
immunostaining.
Because of the sensitivity and rapid turn-around time,
nucleic acid ampliﬁcation technologies such as PCR will
likely be the focus of further advances in respiratory
virus diagnostics. The future will likely promise additional
commercial test kits for molecular detection of respira-
tory viruses, including multiplexed assays. Because of their
exquisite sensitivity, nucleic acid ampliﬁcation tests can
create diagnostic conundrums. Additional research is needed
to elucidate the clinical signiﬁcance of positive PCR results
that are persistent in a patient, and when two or more
respiratory viruses are detected in a single specimen.
Future research on respiratory virus diagnostics should
aim towards the ability to accurately detect a spectrum of
clinically signiﬁcant viruses rapidly enough to aﬀect patient
management and initiation of infection control measures
while keeping the costs aﬀordable. Commercial kits provide4 International Journal of Microbiology
standardization not achievable with laboratory-developed
tests, but at a substantially higher cost. Ultimately, the uti-
lization of molecular testing, particularly highly multiplexed
tests in routine patient management will depend on the
cost/beneﬁt ratio.
Current and future diagnostic options will include
antigen, molecular, and culture-based methods. The perfor-
mance characteristics and limitations of these methods will
vary greatly with the new generations of assays. It is impor-
tant that diagnostic virologists and clinicians understand
these characteristics and limitations.
Acknowledgment
This work is supported in part by NIH Grant no. R01
DC005841.
References
[1] T. Chonmaitree, K. Revai, J. J. Grady et al., “Viral upper
respiratory tract infection and otitis media complication in
young children,” Clinical Infectious Diseases, vol. 46, no. 6, pp.
815–823, 2008.
[ 2 ]J .P .F o x ,C .E .H a l l ,M .K .C o o n e y ,R .E .L u c e ,a n dR .
A. Kronmal, “The Seattle virus watch. II. Objectives, study
population and its observation, data processing and summary
of illnesses,” American Journal of Epidemiology, vol. 96, no. 4,
pp. 270–285, 1972.
[3] A. S. Monto and B. M. Ullman, “Acute respiratory illness in an
American community. The Tecumseh study,” JAMA, vol. 227,
no. 2, pp. 164–169, 1974.
[4] M. R. Stahlberg, “The inﬂuence of form of day care on
occurrence of acute respiratory tract infections among young
children,” Acta Paediatrica Scandinavica, vol. 282, supplement
1, pp. 1–87, 1980.
[5] K. J. Henrickson, “Viral pneumonia in children,” Seminars in
Pediatric Infectious Diseases, vol. 9, no. 3, pp. 217–233, 1998.
[6] A. L. Wright, L. M. Taussig, C. G. Ray, H. R. Harrison, and
C. J. Holberg, “The Tucson children’s respiratory study. II.
Lowerrespiratorytractillnessintheﬁrstyearoflife,”American
Journal of Epidemiology, vol. 129, no. 6, pp. 1232–1246, 1989.
[7] D. Kesebir, M. Vazquez, C. Weibel et al., “Human bocavirus
infection in young children in the United States: molecular
epidemiological proﬁle and clinical characteristics of a newly
emerging respiratory virus,” Journal of Infectious Diseases, vol.
194, no. 9, pp. 1276–1282, 2006.
[8] L.vanderHoek,“Humancoronaviruses:whatdotheycause?”
Antiviral Therapy, vol. 12, no. 4 B, pp. 651–658, 2007.
[ 9 ] J .B a r e n f a n g e r ,C .D r a k e ,N .L e o n ,T .M u e l l e r ,a n dT .
Troutt, “Clinical and ﬁnancial beneﬁts of rapid detection of
respiratory viruses: an outcomes study,” Journal of Clinical
Microbiology, vol. 38, no. 8, pp. 2824–2828, 2000.
[10] A. R. Falsey, Y. Murata, and E. E. Walsh, “Impact of
rapid diagnosis on management of adults hospitalized with
inﬂuenza,” Archives of Internal Medicine, vol. 167, no. 4, pp.
354–360, 2007.
[ 1 1 ]D .E .N o y o l aa n dG .J .D e m m l e r ,“ E ﬀect of rapid diagnosis
on management of inﬂuenza A infections,” Pediatric Infectious
Disease Journal, vol. 19, no. 4, pp. 303–307, 2000.
[12] P. Daley, S. Castriciano, M. Chernesky, and M. Smieja,
“Comparison of ﬂocked and rayon swabs for collection of
respiratory epithelial cells from uninfected volunteers and
symptomatic patients,” Journal of Clinical Microbiology, vol.
44, no. 6, pp. 2265–2267, 2006.
[13] A. Abu-Diab, M. Azzeh, R. Ghneim et al., “Comparison
between pernasal ﬂocked swabs and nasopharyngeal aspirates
for detection of common respiratory viruses in samples from
children,” Journal of Clinical Microbiology,v o l .4 6 ,n o .7 ,p p .
2414–2417, 2008.
[14] P. Walsh, C. L. Overmyer, K. Pham et al., “Comparison of
respiratoryvirusdetectionratesforinfantsandtoddlersbyuse
of ﬂocked swabs, saline aspirates, and saline aspirates mixed
in universal transport medium for room temperature storage
and shipping,” Journal of Clinical Microbiology, vol. 46, no. 7,
pp. 2374–2376, 2008.
[15] K. A. Scansen, B. K. Bonsu, E. Stoner et al., “Comparison
of polyurethane foam to nylon ﬂocked swabs for collection
of secretions from the anterior nares in performance of a
rapid inﬂuenza virus antigen test in a pediatric emergency
department,” Journal of Clinical Microbiology, vol. 48, no. 3,
pp. 852–856, 2010.
[16] G. Ahluwalia, J. Embree, and P. McNicol, “Comparison
of nasopharyngeal aspirate and nasopharyngeal swab spec-
imens for respiratory syncytial virus diagnosis by cell cul-
ture, indirect immunoﬂuorescence assay, and enzyme-linked
immunosorbent assay,” Journal of Clinical Microbiology, vol.
25, no. 5, pp. 763–767, 1987.
[17] D. A. Lennette, “Collection and preparation of specimens for
virological examination,” in Manual of Clinical Microbiology,
P .R .M u rra y ,E .J .Ba r o n ,M .A .P f a ll e r ,F .C .T e n o v e r ,a n dR .H .
Yolken, Eds., p. 870, American Society for Microbiology Press,
Washington, DC, USA, 6th edition, 1995.
[18] K. McIntosh, R. M. Hendry, M. L. Fahnestock, and L. T.
Pierik, “Enzyme-linked immunosorbent assay for detection
of respiratory syncytial virus infection: application to clinical
samples,” Journal of Clinical Microbiology,v o l .1 6 ,n o .2 ,p p .
329–333, 1982.
[ 1 9 ]K .H .C h a n ,J .S .M .P e i r i s ,W .L i m ,J .M .N i c h o l l s ,a n dS .
S. Chiu, “Comparison of nasopharyngeal ﬂocked swabs and
aspiratesforrapiddiagnosisofrespiratoryvirusesinchildren,”
Journal of Clinical Virology, vol. 42, no. 1, pp. 65–69, 2008.
[20] K. Agoritsas, K. Mack, B. K. Bonsu, D. Goodman, D. Salamon,
and M. J. Marcon, “Evaluation of the Quidel QuickVue
test for detection of inﬂuenza A and B viruses in the
pediatricemergencymedicinesettingbyuseofthreespecimen
collection methods,” Journal of Clinical Microbiology, vol. 44,
no. 7, pp. 2638–2641, 2006.
[21] S. Lambert, D. M. Whiley, N. T.o’Neill et al., “Comparing
nose-throat swabs and nasopharyngeal aspirates collected
from children with symptoms for respiratory virus identiﬁ-
cation using real-time polymerase chain reaction,” Pediatrics,
vol. 122, no. 3, pp. e615–e620, 2008.
[22] S. B. Lambert, K. M. Allen, and T. M. Nolan, “Parent-collected
respiratory specimens-A novel method for respiratory virus
and vaccine eﬃcacy research,” Vaccine, vol. 26, no. 15, pp.
1826–1831, 2008.
[23] C. Moore, S. Corden, J. Sinha, and R. Jones, “Dry cotton or
ﬂocked respiratory swabs as a simple collection technique for
the molecular detection of respiratory viruses using real-time
NASBA,” Journal of Virological Methods, vol. 153, no. 2, pp.
84–89, 2008.International Journal of Microbiology 5
[24] C. C. Ginocchio, “Detection of respiratory viruses using non-
molecularbasedmethods,”JournalofClinicalVirology,vol.40,
no. 1, pp. S11–S14, 2007.
[25] J. A. Englund, P. A. Piedra, A. Jewell, K. Patel, B. B. Baxter, and
E. Whimbey, “Rapid diagnosis of respiratory syncytial virus
infections in immunocompromised adults,” Journal of Clinical
Microbiology, vol. 34, no. 7, pp. 1649–1653, 1996.
[26] N. Kawai, H. Ikematsu, N. Iwaki et al., “Longer virus shedding
in inﬂuenza B than in inﬂuenza A among outpatients treated
with oseltamivir,” Journal of Infection, vol. 55, no. 3, pp. 267–
272, 2007.
[27] J. C. Abanses, M. D. Dowd, S. D. Simon, and V. Sharma,
“Impact of rapid inﬂuenza testing at triage on management of
febrile infants and young children,” Pediatric Emergency Care,
vol. 22, no. 3, pp. 145–149, 2006.
[28] A. R. Falsey, Y. Murata, and E. E. Walsh, “Impact of
rapid diagnosis on management of adults hospitalized with
inﬂuenza,” Archives of Internal Medicine, vol. 167, no. 4, pp.
354–360, 2007.
[29] C. C. Blyth, J. R. Iredell, and D. E. Dwyer, “Rapid-test
sensitivity for novel swine-origin inﬂuenza A (H1N1) virus in
humans,” The New England Journal of Medicine, vol. 361, no.
25, p. 2493, 2009.
[30] Centers for Disease Control and Prevention, “Evaluation
of rapid inﬂuenza diagnostic tests for detection of novel
inﬂuenza A (H1N1) virus—United States, 2009,” Morbidity
and Mortality Weekly Report, vol. 58, no. 30, pp. 826–829,
2009.
[31] C. C. Ginocchio, F. Zhang, R. Manji et al., “Evaluation of
multiple test methods for the detection of the novel 2009
inﬂuenza A (H1N1) during the New York City outbreak,”
Journal of Clinical Virology, vol. 45, no. 3, pp. 191–195, 2009.
[32] J.Aslanzadeh,X.Zheng,H.Lietal.,“Prospectiveevaluationof
rapid antigen tests for diagnosis of respiratory syncytial virus
and human metapneumovirus infections,” Journal of Clinical
Microbiology, vol. 46, no. 5, pp. 1682–1685, 2008.
[33] D. C. Vinh, D. Newby, H. Charest, and J. McDonald, “Eval-
uation of a commercial direct ﬂuorescent-antibody assay for
human metapneumovirus in respiratory specimens,” Journal
of Clinical Microbiology, vol. 46, no. 5, pp. 1840–1841, 2008.
[34] T. Ganzenmueller, J. Kluba, B. Hilfrich et al., “Comparison
of the performance of direct ﬂuorescent antibody staining,
a point-of-care rapid antigen test and virus isolation with
that of RT-PCR for the detection of novel 2009 inﬂuenza A
(H1N1) virus in respiratory specimens,” Journal of Medical
Microbiology, vol. 59, no. 6, pp. 713–717, 2010.
[35] A. K. Shetty, E. Treynor, D. W. Hill, K. M. Gutierrez, A.
Warford, and E. J. Baron, “Comparison of conventional
viral cultures with direct ﬂuorescent antibody stains for
diagnosis of community-acquired respiratory virus infections
in hospitalized children,” Pediatric Infectious Disease Journal,
vol. 22, no. 9, pp. 789–794, 2003.
[36] J. Barenfanger, C. Drake, T. Mueller, T. Troutt, J. O’Brien, and
K. Guttman, “R-Mix cells are faster, at least as sensitive and
marginally more costly than conventional cell lines for the
detection of respiratory viruses,” Journal of Clinical Virology,
vol. 22, no. 1, pp. 101–110, 2001.
[37] P. R. LaSala, K. K. Bufton, N. Ismail, and M. B. Smith,
“Prospective comparison of R-mixTM shell vial system with
direct antigen tests and conventional cell culture for respira-
tory virus detection,” Journal of Clinical Virology, vol. 38, no.
3, pp. 210–216, 2007.
[38] W. Wang, E. N. Butler, V. Veguilla et al., “Establishment of
retroviral pseudotypes with inﬂuenza hemagglutinins from
H1, H3, and H5 subtypes for sensitive and speciﬁc detection
of neutralizing antibodies,” Journal of Virological Methods, vol.
153, no. 2, pp. 111–119, 2008.
[39] R. Manji, M. Lotlikar, F. Zhang, and C. C.Ginocchio, “Clinical
evaluation of NucliSENS magnetic extraction and NucliSENS
analytical speciﬁc reagents for the real-time detection of
respiratory syncytial virus (RSV) in paediatric respiratory
specimens,” Journal of Clinical Pathology, vol. 62, no. 11, pp.
998–1002, 2009.
[40] E.T.Martin,J.Taylor,J.Kuypersetal.,“Detectionofbocavirus
in saliva of children with and without respiratory illness,”
JournalofClinicalMicrobiology,vol.47,no.12,pp.4131–4132,
2009.
[41] R. B. Clark, M. A. Lewinski, M. J. Loeﬀelholz, and R.
J. Tibbetts, “Cumitech 31A, veriﬁcation and validation of
procedures,” in Clinical Microbiology Laboratory,S .E .S h a r p ,
Ed., ASM Press, Washington, DC, USA, 2009.
[42] K. J. Henrickson and C. B. Hall, “Diagnostic assays for
respiratory syncytial virus disease,” Pediatric Infectious Disease
Journal, vol. 26, no. 11, pp. S36–S40, 2007.
[43] J. B. Mahony, “Detection of respiratory viruses by molecular
methods,” Clinical Microbiology Reviews,v o l .2 1 ,n o .4 ,p p .
716–747, 2008.
[44] T. Jartti, L. Jartti, V. Peltola, M. Waris, and O. Ruuska-
nen, “Identiﬁcation of respiratory viruses in asymptomatic
subjects: asymptomatic respiratory viral infections,” Pediatric
InfectiousDiseaseJournal,vol.27,no.12,pp.1103–1107, 2008.
[ 4 5 ]M .M .v a nd e rZ a l m ,B .E .v a nE w i j k ,B .W i l b r i n k ,C .
S. P. M. Uiterwaal, T. F. W. Wolfs, and C. K. van der
Ent, “Respiratory pathogens in children with and without
respiratory symptoms,” Journal of Pediatrics, vol. 154, no. 3,
pp. 396–400, 2009.
[46] B. Winther, C. M. Alper, E. M. Mandel, W. J. Doyle, and
J. O. Hendley, “Temporal relationships between colds, upper
respiratoryvirusesdetectedbypolymerasechainreaction,and
otitis media in young children followed through a typical cold
season,” Pediatrics, vol. 119, no. 6, pp. 1069–1075, 2007.
[47] S. U. Kalu, M. Loeﬀelholz, E. Beck et al., “Persistence of
adenovirus nucleic acids in nasopharyngeal secretions: a
diagnostic conundrum,” Pediatric Infectious Disease Journal,
vol. 29, no. 8, pp. 746–750, 2010.
[48] T. Jartti, P. Lehtinen, T. Vuorinen, M. Koskenvuo, and O.
Ruuskanen, “Persistence of rhinovirus and enterovirus RNA
after acute respiratory illness in children,” Journal of Medical
Virology, vol. 72, no. 4, pp. 695–699, 2004.
[49] J. Jacques, H. Moret, F. Renois, N. L´ evˆ eque, J. Motte, and L.
Andr´ eoletti, “Human Bocavirus quantitative DNA detection
in French children hospitalized for acute bronchiolitis,” Jour-
nal of Clinical Virology, vol. 43, no. 2, pp. 142–147, 2008.